Important notice before you order
Only purchase Intex Pharma Retatrutide from this official store at intexpharmaresearch.uk. Do not buy from any third-party website or site impersonating Intex Pharma. Products sold elsewhere may be counterfeit and your order will not be protected.
Multi-vial discount
Use code RETA2MG20 for 20% off when ordering two or more vials. Min. spend £250.
Bitcoin discount
Use code INTEXBTC15 for 15% off your entire order when paying with Bitcoin.
What is Intex Pharma Retatrutide 2mg?
Intex Pharma Retatrutide 2mg is pharmaceutical grade Retatrutide (LY3437943) supplied as 2mg of lyophilised powder in a vial for subcutaneous injection following reconstitution with bacteriostatic water. Retatrutide is the world’s most advanced triple hormone receptor agonist, simultaneously activating GLP-1, GIP and glucagon receptors to reduce appetite, improve metabolic health and raise energy expenditure. The vial format gives users full control over dose titration, making it the preferred choice for those starting at very low doses or managing protocols that require flexibility. Available from the Intex Pharma shop at £125.00 with same day UK despatch.
For users who prefer a no-preparation, pre-measured format, the Intex Pharma Retatrutide Prefilled Pen at £155.00 is also available. Both formats contain the same pharmaceutical grade Retatrutide verified by Janoshik Analytical before despatch.
How Retatrutide 2mg works
Retatrutide activates three distinct hormone receptors through a single molecule, producing layered weight loss effects that no single or dual agonist can replicate. Its six-day half-life supports once-weekly subcutaneous injection with steady plasma concentrations maintained between doses.
Clinical evidence
The Phase 2 randomised controlled trial published in the New England Journal of Medicine enrolled 338 adults with obesity and no type 2 diabetes over 48 weeks. Retatrutide at 12mg produced mean weight loss of 24.2% and at 8mg produced 22.8%. Every participant receiving 12mg lost at least 5% of body weight. Among this group, 83% achieved at least 15% weight loss. These are the largest reductions recorded in a Phase 2 obesity pharmacotherapy trial.
Phase 3 TRIUMPH-4 results announced by Eli Lilly in December 2025 reported average weight loss of 71.2 lbs alongside significant relief from osteoarthritis pain, confirming that the Phase 2 efficacy signal translates to large-scale Phase 3 populations.
How to reconstitute Intex Pharma Retatrutide 2mg
Retatrutide 2mg must be reconstituted with bacteriostatic water before injection. Do not use plain sterile water. Bacteriostatic water contains benzyl alcohol which preserves the peptide for up to 30 days refrigerated.
Dose reference at 1mg per ml concentration
Dosing protocol
The Retatrutide 2mg vial format is particularly suited to users who want to start at very low doses such as 0.25mg or 0.5mg per week and escalate gradually based on response. The standard titration protocol begins at 1mg weekly and escalates through 2mg, 4mg and then to maintenance doses. At 1mg per ml reconstitution, one 2mg vial provides exactly two weekly doses at the 1mg starting level or four doses at 0.5mg for users who prefer a slower initial titration.
Inject subcutaneously once weekly into the abdomen, thigh or upper arm. Rotate injection sites weekly. Use a 29 or 30 gauge insulin syringe for comfortable subcutaneous administration. Many UK users report significant appetite suppression and early weight loss at doses of 1 to 2mg per week without needing to escalate further, particularly in the first two to three months of treatment.
Side effects
- Nausea. Most common during dose escalation. Eating smaller, lower-fat meals and not eating immediately before the weekly injection reduces this significantly.
- Reduced appetite. The intended effect of the compound. Ensuring adequate protein, hydration and micronutrient intake is important during significant appetite suppression.
- Vomiting and diarrhoea. More common with rapid dose escalation. Spending at least four weeks at each dose level before moving higher substantially reduces gastrointestinal side effects.
- Fatigue. Reported in the early weeks of treatment. Typically resolves as the body adapts to the new metabolic environment.
- Injection site reactions. Mild redness or tenderness at the injection site. Rotating sites and injecting slowly with a fine gauge needle minimises this.
Retatrutide should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, in line with the precautionary labelling applied to all GLP-1 receptor agonist class compounds.
Frequently asked questions about Intex Pharma Retatrutide 2mg
What is Retatrutide 2mg used for?
Intex Pharma Retatrutide 2mg is used for weight loss and metabolic health improvement through triple hormone receptor agonism at GLP-1, GIP and glucagon receptors. The vial format allows flexible dose titration starting from 0.25mg or 0.5mg per week for users who want to begin at very low doses and escalate gradually. At the doses studied in clinical trials, Retatrutide produced mean weight loss of 22 to 24% over 48 weeks, more than any currently approved GLP-1 therapy.
How do I mix Retatrutide 2mg for injection?
Add 2ml of bacteriostatic water to the 2mg vial to produce a concentration of 1mg per ml. Inject the water slowly down the side of the vial wall, not directly at the powder. Gently swirl until fully dissolved. Do not shake. Refrigerate immediately and use within 30 days. Always use bacteriostatic water rather than plain sterile water to preserve the reconstituted peptide for the full 30-day window.
What is the starting dose for Retatrutide 2mg?
The standard starting dose from the clinical trial protocols is 1mg per week. The vial format allows users to start at 0.5mg or even 0.25mg per week for a slower initial titration, which is useful for users who are sensitive to GLP-1 gastrointestinal side effects. At 1mg per ml reconstitution, the 2mg vial provides two weekly doses at 1mg each, making it practical for a two-week starting period before ordering the next vials.
How is the Retatrutide 2mg vial different from the prefilled pen?
The 2mg vial requires reconstitution with bacteriostatic water and dose drawing with an insulin syringe, which gives full control over the exact dose administered. This makes it particularly useful for very low starting doses and flexible titration. The prefilled pen requires no preparation and delivers a pre-measured dose directly, making it more convenient for users who want a simpler administration process. Both contain the same pharmaceutical grade Retatrutide verified by Janoshik Analytical.
How many vials of Retatrutide 2mg do I need per month?
At 1mg per week starting dose, one 2mg vial provides two weekly doses, meaning approximately two vials per month. At 2mg per week, one vial provides one weekly dose, meaning four vials per month. As the dose escalates to 4mg or 8mg per week, the monthly requirement increases accordingly. Ordering two vials at a time qualifies for the 20% discount with code RETA2MG20 and ensures you do not run out between deliveries.
Is Intex Pharma Retatrutide 2mg pharmaceutical grade?
Yes. Every batch of Intex Pharma Retatrutide is independently tested by Janoshik Analytical using HPLC and mass spectrometry to confirm peptide identity, purity and concentration. The Certificate of Analysis for the current batch is available in the product gallery on the Intex Pharma shop before you order. Store refrigerated between 2 and 8 degrees Celsius in powder form and use within 30 days once reconstituted.
Related guides from Intex Pharma
Reviews
There are no reviews yet.